Efficacy and Safety of CRC01 in Participants With Severe, Refractory Systemic Lupus Erythematosus
Clinical trial NCT07364396 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07364396
- Sponsor
- Curocell Inc.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-02-01
- Primary completion
- 2030-06-01
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.